Completed projects

Donate

Code	Title	Period	Principal Investigator at the Insitute of Oncology
J3-7460	Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model	26. 8. 2024 - 31. 12. 2018	prof. dr. Strojan Primož/Institute of Oncology Ljubljana
Z3-50112	Irradioation and learned immunity: The role of NK cells	1. 10. 2023 - 31. 5. 2026	Tim Božič, PhD
J3-4504	Uncovering the glioblastoma microenvironment to enhance the therapy	1. 10. 2022 - 30. 9. 2025	Metka Novak, PhD
J7-4491	Development of integrated multi-channel artificial nose for detection of cancer	1. 10. 2022 - 30. 9. 2025	Prof. Igor Muševič PhD
J1-4417	Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy	1. 10. 2022 - 30. 9. 2025	Prof. Matej Sova PhD
V3-2239	Needs assessment, identification of criteria and development of a model for the organization of palliative cancer care at the national level	1. 10. 2022 - 1. 10. 2025	Vesna Zadnik, PhD
V3-2236	Assessment of the potential impact of incineration and co-incineration of waste on human health effects: a model study on the case of the Salonit Anhovo cement plant	1. 10. 2022 - 28. 2. 2025	Vesna Zadnik, PhD
J7-4635	MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy	1. 10. 2022 - 30. 9. 2025	Prof. Lucija Peterlin Masic PhD
J7-4540	Socio-economic consequences of cancer from the perspective of the individual and society including the impact of COVID-19 pandemic	1. 10. 2022 - 31. 3. 2026	Asst Prof. Ivica Ratosa
BI-US-22-24-070	Bridging the gap between three-dimensional biomimetic vascular models and in vivo tumor vasculature	1. 7. 2022 - 30. 6. 2024	dr. Boštjan Markelc
BI-US-22-24-026	Factors affecting combined electrochemotherapy with immunogene therapy of cancer	1. 7. 2022 - 30. 6. 2024	Acad. Prof. Serša Gregor
J3-3062	Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer	1. 10. 2021 - 30. 9. 2025	Prof. Matjaž Jeras, Assist. Simona Borstnar
J2-3059	Online adaptive re-planning in proton and radiotherapy	1. 10. 2021 - 31. 3. 2025	prof. Žiga Špiclin and prof. Primoz Strojan
J3-3084	Inducible programming of CAR T cell intrinsic properties for cancer immunotherapy	1. 9. 2021 - 31. 8. 2024	dr. Anže Smole (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J3-3083	Vascularization and vascular effects as predictive factors for local ablative techniques	1. 9. 2021 - 30. 9. 2025	acad. prof. dr. Serša Gregor
N1-0197	Improving breast cancer screening through dynamic big data analytics of Quantitative Imaging Biomarkers	1. 1. 2021 - 31. 12. 2024	Assoc. Prof. Robert Jeraj /Mateja Krajc
V3-2032	The impact of COVID-19 on the cancer management in Slovenia	1. 10. 2020 - 30. 9. 2022	Tina Žagar PhD
J3-2537	New method for estimating life-years gained in population-based cancer screening programmes (S-LYG)	1. 9. 2020 - 31. 8. 2024	Prof. Vesna Zadnik PhD
Z3-2651	Electrochemotherapy as in situ vaccination therapy	1. 9. 2020 - 31. 8. 2023	dr. Katja Uršič Valentinuzzi
L3-2622	Biological markers of development, progression and treatment response in asbestos related diseases	1. 9. 2020 - 31. 8. 2023	Assoc. Prof. Vita Dolžan, Prof. Viljem Kovac
J4-2594	The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity	1. 9. 2020 - 31. 8. 2023	prof. dr. Mateja Erdani Kreft (Faculty of Medicine)/ prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J4-2546	Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours	1. 9. 2020 - 31. 8. 2023	prof. dr. Nataša Tozon (Veterinary Faculty)/prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
J3-2529	Role of endothelium in tumor response to radiotherapy	1. 9. 2020 - 31. 8. 2023	dr. Boštjan Markelc
J3-2528	Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors	1. 9. 2020 - 31. 8. 2023	prof. dr. Maja Čemažar
J3-2527	New approaches for prediction of cardiotoxicity in breast cancer radiotherapy	1. 9. 2020 - 31. 8. 2023	Assist. Prof. Tanja Marinko
J3-2524	Minimally invasive diagnostic approaches in brain tumours using circulating cell-free nucleic acids	1. 9. 2020 - 31. 8. 2023	Assoc. Prof. Jože Pižem
V3-1911	Slovenian genome project	1. 11. 2019 - 31. 10. 2022	Assoc. Prof. Borut Peterlin
V3-1907	Development of indicators and methodology for monitoring the late effects of cancer treatment in childhood at national level	1. 11. 2019 - 31. 10. 2021	Assoc. Prof. Vesna Zadnik
V3-1906	Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022	1. 11. 2019 - 30. 4. 2023	Prof. Nikola Besic
J2-1732	Computer-assisted medical image analysis for proton and radiotherapy treatment planning	1. 7. 2019 - 30. 6. 2022	Prof. Tomaž Vrtovec
Z3-1871	Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer	1. 7. 2019 - 30. 6. 2021	dr. Maša Bošnjak
J3-1760	The role of imaging and laboratory markers in the evaluation of nature and growth of thyroid nodules	1. 7. 2019 - 30. 6. 2022	Prof. Katja Zaletel / Prof. Nikola Besic
J3-1753	Molecular predictors of radiation treatment response in breast cancer	1. 7. 2019 - 30. 6. 2022	Asst. Prof. Katja Goricar, Asst. Prof. Tanja Marinko
J3-9269	Clinical pharmacological approach to optimization of therapeutic concentration of bleomycin treatment with electrochemotherapy	1. 7. 2018 - 30. 6. 2021	acad. prof. dr. Serša Gregor
J2-9225	Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields	1. 7. 2018 - 30. 6. 2021	prof. dr. Damijan Miklavčič (Faculty of Electrical Engineering/ acad. prof. dr. Gregor Serša Institute of Oncology Ljubljana
V3-1720 (B)	Analysis and estimation of requirements of human resources for cancer treatment in Slovenia	1. 4. 2018 - 31. 3. 2020	Prof. Branko Zakotnik PhD
V3-1718	Health risk assessment for exposures of children to low-frequency electric and magnetic (EM) fields in Slovenia	1. 4. 2018 - 31. 3. 2021	Prof. Tadej Kotnik PhD, Prof. Vesna Zadnik PhD
V3-1713 (B)	Comprehensive analysis of management of urological cancer patients with an assessment of possible delays in referrals, realization of diagnostics procedures and first treatment	1. 4. 2018 - 31. 3. 2020	Assoc. Prof. Vesna Zadnik PhD
Z3-8204	Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect	1. 4. 2018 - 31. 3. 2020	dr. Tanja Jesenko
/	Cancer incidence at dravsko polje: geographical analysis of cancer incidence in the municipality of Rače-Fram and surrounding settlements	1. 1. 2018 - 31. 12. 2019	Prof Vesna Zadnik PhD
J5-9336	Opportunities and dangers of online health communities for healthcare	1. 1. 2018 - 1. 1. 2022	Asst. Prof. Rok Petrič
BI-AT-18-19-003	Cancer stem cell (CSC)-associated exosomes as regulators of tumor radiation response	1. 1. 2018 - 31. 12. 2019	prof. dr. Maja Čemažar
J4-8227	Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy	1. 5. 2017 - 30. 4. 2020	prof. dr. Kos Janko (Univerza v Ljubljani, Fakulteta za farmacijo/IJS)/ acad. prof. dr. Gregor Serša (Onkološki inštitut)
L3-8203	Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases	1. 5. 2017 - 30. 6. 2020	Assoc. Prof. Viljem Kovač
J3-8202	Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and interleukin-12 gene therapy boost	1. 5. 2017 - 30. 4. 2021	prof. dr. Maja Čemažar
J1-8140	Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard	1. 5. 2017 - 30. 4. 2021	prof. dr. Filipič Metka (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)
/	Implementation of the clinical pathway for dietary treatment of hospitalized patients, screening tools for dietary treatment of outpatients and guidelines for the physical activity of patients	1. 1. 2017 - 31. 12. 2019	Nada Rotovnik Kozjek
J3-8210	Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention	1. 1. 2017 - 1. 1. 2020	Sr. Res. Fell. Srdjan Novaković
V3-1638 (C)	Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population	1. 10. 2016 - 30. 9. 2019	Assoc. Prof. Vesna Zadnik PhD
L2-7550	Electrospun nanofibrous materials for solid state drug delivery system	1. 3. 2016 - 28. 2. 2019	prof. dr. Igor Emri /acad. prof. dr. Gregor Serša (Institute of Oncology Ljubljana)
J3-7494	Tunneling nanotubes for innovative urinary bladder cancer treatment	1. 1. 2016 - 1. 1. 2018	Prof. Maja Cemazar PhD
J3-7372	Molecular biomarkers and biomarker-driven therapy in lung cancer	1. 1. 2016 - 31. 12. 2018	Prof. Tanja Čufer, Assoc. Prof. Viljem Kovač
J3-7272 (A)	Methods of estimation of key indicators in population cancer survival	1. 1. 2016 - 31. 12. 2018	prof. dr. Pohar Perme Maja (Univerza v Ljubljani, Medicinska fakulteta), prof. dr. Vesna Zadnik (Onkološki inštitut)
IP-0302	Lifelong Follow-Up of Survivors of Childhood and Adolescent Cancer and Related Translational Trials	1. 1. 2009 - 31. 12. 2019	Asst. Prof. Lorna Zadravec Zaletel PhD

Other national projects

Code	Title	Period	Principal Investigator at the Insitute of Oncology
/	Training Program for Healthcare Professionals and Associates to Acquire Specialized Knowledge in Clinical Nutrition Co-financed by the Ministry of Health of the Republic of Slovenia (2023–2025)	1. 1. 2023 - 31. 12. 2025	Assoc. Prof. Nada Rotovnik Kozjek, MD, PhD
/	Training for healthcare professionals and associates to acquire specialised skills in clinical nutrition	1. 1. 2023 - 1. 1. 2025	Nada Rotovnik Kozjek, PhD
/	Training and education of healthcare workers for implementation of the clinical pathway of nutritional care at the tertiary and secondary levels of healthcare	1. 1. 2020 - 1. 1. 2022	Nada Kozjek Rotovnik

Name	Purpose	Lifetime
_pk_id	Counting web site visitors.	13 months
_pk_ref	Tracking from which sites users come to our web pages.	6 months
_pk_ses	Counting web site visits.	30 minutes
_ga	Used to distinguish users.	2 years
_ga_--container-id--	Persists session state.	2 years

National projects

Other national projects